Published in Circulation on December 16, 1997
A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ (2007) 2.35
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31
Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol (2011) 1.72
Differences between clinical trials and postmarketing use. Br J Clin Pharmacol (2004) 1.54
Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect. CMAJ (2005) 1.43
Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No. BMJ (2007) 1.31
Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol (2010) 1.13
Management of cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: 2002-2012 literature review. J Am Geriatr Soc (2013) 1.03
Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation (2013) 1.02
Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study. Arch Med Sci (2013) 1.01
Sex/gender medicine. The biological basis for personalized care in cardiovascular medicine. Circ J (2009) 1.01
Dyslipidemia: evidence of efficacy of the pharmacological and non-pharmacological treatment in the elderly. J Geriatr Cardiol (2012) 0.90
Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model. J Gen Intern Med (2003) 0.90
Sex differences in the effectiveness of statins after myocardial infarction. CMAJ (2007) 0.90
Cholesterol and coronary heart disease: screening and treatment. Qual Health Care (1998) 0.89
Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies. J Womens Health (Larchmt) (2010) 0.88
The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice. Med Sci Monit (2011) 0.87
Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults. Ann Pharmacother (2013) 0.85
The impact of statin therapy on long-term cardiovascular outcomes in an outpatient cardiology practice. Arch Med Sci (2012) 0.84
Use of statin therapy to reduce cardiovascular risk in older patients. Curr Gerontol Geriatr Res (2010) 0.84
Lipid-lowering therapy in older persons. Arch Med Sci (2015) 0.82
Disorders of lipid metabolism and chronic kidney disease in the elderly. Semin Nephrol (2009) 0.82
Management of dyslipidemia in women in the post-hormone therapy era. J Gen Intern Med (2005) 0.82
Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial. Can J Cardiol (2007) 0.80
The impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study. BMC Health Serv Res (2009) 0.80
Atorvastatin and cardiovascular risk in the elderly--patient considerations. Clin Interv Aging (2008) 0.79
Prospective care of heart failure in Japan: lessons from CHART studies. EPMA J (2011) 0.79
Statin use among older Finns stratified according to cardiovascular risk. Eur J Clin Pharmacol (2012) 0.78
Lipid-modifying therapy in the elderly. Vasc Health Risk Manag (2015) 0.77
Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism. Sci Rep (2015) 0.77
Blood cholesterol trends 2001-2011 in the United States: analysis of 105 million patient records. PLoS One (2013) 0.77
Management of hyperlipidemia with statins in the older patient. Clin Interv Aging (2006) 0.76
Cholesterol and cardiovascular disease in the elderly. Facts and gaps. Aging Dis (2013) 0.76
Lowering cholesterol in patients with coronary heart disease: are we ready yet? Circulation (1997) 0.75
Comparison of serum lipid management between elderly and non-elderly patients with and without coronary heart disease (CHD). Prev Med Rep (2016) 0.75
Risk stratification in very old adults: how to best gauge risk as the basis of management choices for patients aged over 80. Prog Cardiovasc Dis (2014) 0.75
Statins and their interactions with other lipid-modifying medications: safety issues in the elderly. Ther Adv Drug Saf (2012) 0.75
Statinopause. J Gen Intern Med (2014) 0.75
Statins for stroke should be considered in biologically fit people over 75. BMJ (2000) 0.75
Cancer risk in older people receiving statin therapy: a meta-analysis of randomized controlled trials. J Geriatr Cardiol (2016) 0.75
Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter? Scand J Prim Health Care (2015) 0.75
Influences of age, sex, and LDL-C change on cardiovascular risk reduction with pravastatin treatment in elderly Japanese patients: A post hoc analysis of data from the Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE). Curr Ther Res Clin Exp (2006) 0.75
Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter? Vasc Health Risk Manag (2006) 0.75
Management strategies of dyslipidemia in the elderly: 2005. MedGenMed (2005) 0.75
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23
Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods (1989) 9.42
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA (2001) 9.16
Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care (1997) 7.85
Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J (1991) 6.35
The global carbon cycle: a test of our knowledge of earth as a system. Science (2000) 5.61
Randomized evaluation of pulse oximetry in 20,802 patients: II. Perioperative events and postoperative complications. Anesthesiology (1993) 4.02
High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care (1998) 3.94
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med (1992) 3.87
Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis (1998) 3.50
Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil (1968) 3.38
Conversion of diploidy to haploidy. Nature (2000) 3.28
[The Scandinavian Simvastatin Survival Study]. Ugeskr Laeger (1995) 3.25
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation (1990) 2.89
Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev (1987) 2.88
Impacts of atmospheric anthropogenic nitrogen on the open ocean. Science (2008) 2.85
Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial. Ann Intern Med (2000) 2.82
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care (1998) 2.70
NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes (1994) 2.67
Randomized evaluation of pulse oximetry in 20,802 patients: I. Design, demography, pulse oximetry failure rate, and overall complication rate. Anesthesiology (1993) 2.65
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer (1997) 2.64
Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I. Eur Heart J (1999) 2.64
Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A (1975) 2.59
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
Solidarity and equity: new ethical frameworks for genetic databases. Nat Rev Genet (2001) 2.51
The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol (1991) 2.50
Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology (1995) 2.44
Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia (1993) 2.41
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study. Lancet (1978) 2.32
Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S) Eur Heart J (1996) 2.31
Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J (2002) 2.31
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med (2000) 2.27
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat. J Clin Invest (1975) 2.15
Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med (1995) 2.15
Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation (2001) 2.11
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. J Card Fail (1997) 2.08
Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA (1986) 2.08
Non-cardiovascular disease mortality and diabetes mellitus. Lancet (1997) 2.01
Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study. Am J Transplant (2005) 2.01
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am J Med (1996) 2.00
Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A (1978) 1.98
Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation (1998) 1.98
Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke (1996) 1.97
Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy. Arterioscler Thromb Vasc Biol (1999) 1.95
Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation (1993) 1.90
Purification of mouse interferon by affinity chromatography on anti-interferon globulin-sepharose. J Immunol (1973) 1.88
Beta-blockers and sudden cardiac death. Ann Intern Med (1995) 1.83
Why ruminators are poor problem solvers: clues from the phenomenology of dysphoric rumination. J Pers Soc Psychol (1999) 1.82
Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J (1996) 1.82
Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens (1998) 1.80
Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation (2000) 1.79
Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol (2000) 1.79
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med (1997) 1.79
5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol (1997) 1.79
Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care (1996) 1.78
Screening of family members of patients with premature coronary heart disease; results from the EUROASPIRE II family survey. Eur Heart J (2003) 1.77
Recessive inheritance of adult-type lactose malabsorption. Lancet (1973) 1.69
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
Predicting zygosity in Norwegian twin pairs born 1915-1960. Clin Genet (1983) 1.68
Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies. J Immunol (1975) 1.67
Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia (2004) 1.67
Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet (1985) 1.66